Harvard Bioscience Total Current Liabilities 2010-2025 | HBIO

Harvard Bioscience total current liabilities from 2010 to 2025. Total current liabilities can be defined as the sum of all liabilities classified as current for having maturities of less than one year.
Harvard Bioscience Annual Total Current Liabilities
(Millions of US $)
2024 $55
2023 $27
2022 $23
2021 $25
2020 $21
2019 $25
2018 $25
2017 $14
2016 $15
2015 $19
2014 $18
2013 $16
2012 $10
2011 $10
2010 $11
2009 $12
Harvard Bioscience Quarterly Total Current Liabilities
(Millions of US $)
2025-03-31 $56
2024-12-31 $55
2024-09-30 $23
2024-06-30 $23
2024-03-31 $26
2023-12-31 $27
2023-09-30 $24
2023-06-30 $23
2023-03-31 $23
2022-12-31 $23
2022-09-30 $21
2022-06-30 $23
2022-03-31 $27
2021-12-31 $25
2021-09-30 $24
2021-06-30 $23
2021-03-31 $21
2020-12-31 $21
2020-09-30 $21
2020-06-30 $23
2020-03-31 $23
2019-12-31 $25
2019-09-30 $22
2019-06-30 $21
2019-03-31 $24
2018-12-31 $25
2018-09-30 $19
2018-06-30 $22
2018-03-31 $22
2017-12-31 $14
2017-09-30 $14
2017-06-30 $13
2017-03-31 $14
2016-12-31 $15
2016-09-30 $14
2016-06-30 $15
2016-03-31 $16
2015-12-31 $19
2015-09-30 $17
2015-06-30 $21
2015-03-31 $20
2014-12-31 $18
2014-09-30 $16
2014-06-30 $16
2014-03-31 $15
2013-12-31 $16
2013-09-30 $13
2013-06-30 $13
2013-03-31 $13
2012-12-31 $10
2012-09-30 $10
2012-06-30 $10
2012-03-31 $11
2011-12-31 $10
2011-09-30 $10
2011-06-30 $10
2011-03-31 $11
2010-12-31 $11
2010-09-30 $10
2010-06-30 $10
2010-03-31 $12
2009-12-31 $12
2009-09-30 $22
2009-06-30 $9
2009-03-31 $10
Sector Industry Market Cap Revenue
Computer and Technology Scientific Instruments Manufacturing $0.021B $0.094B
HARVARD BIOSCIENCE develops, manufactures and markets tools used in drug discovery research at pharmaceutical and biotechnology companies, universities and government laboratories.
Stock Name Country Market Cap PE Ratio
Bruker (BRKR) United States $6.334B 17.79
Kewaunee Scientific (KEQU) United States $0.162B 10.53